Skip to main content

Table 1 Baseline characteristics of the two groups

From: The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism

Items Normal group
(n = 117)
Hypogonadism group
(n = 81)
t/χ2 P value
Age (years, mean ± SD) 56.8 ± 5.82 56.7 ± 5.69 0.132 0.895
Course of disease (years, mean ± SD) 5.26 ± 0.36 5.22 ± 0.45 0.666 0.506
BMI (kg/m2, mean ± SD) 25.11 ± 1.33 26.22 ± 1.15 -6.609 <0.001
WC (cm, mean ± SD) 94.01 ± 4.39 96.69 ± 4.23 -4.287 <0.001
SBP (mmHg, mean ± SD) 132 ± 14 135 ± 12 -1.57 0.118
DBP (mmHg, mean ± SD) 84 ± 8 86 ± 9 -1.643 0.102
GA, n ( %) 9 (7.69) 8 (9.88) 0.291 0.59
CHD, n ( %) 7 (5.98) 5 (6.17) 0.003 0.956
Hypertension, n ( %) 60 (51.28) 43 (53.09) 0.062 0.803
T2DM, n ( %)) 15 (12.82) 11 (13.58) 0.024 0.877
NAFLD, n ( %) 27 (23.08) 39 (48.15) 13.538 <0.001
HLP, n ( %) 48 (49.57) 58 (59.26) 17.993 <0.001
OB, n ( %) 39 (40.17) 47 (48.15) 11.877 <0.001
Smoking history, n ( %) 23 (19.66) 17 (20.99) 0.052 0.82
Drinking history, n ( %) 36 (30.77) 26 (32.10) 0.039 0.843
  1. BMI body mass index; WC waist circumference; SBP systolic blood pressure; DBP diastolic blood pressure; GA gouty arthritis; CHD coronary heart disease: T2DM type 2 diabetes mellitus; NAFLD non-alcoholic fatty liver disease; HLP hyperlipidaemia; OB obesity